Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Fund Letter | Bernard HornPolaris Global Equity | Jazz Pharmaceuticals plc $JAZZ• NASDAQ | BiotechnologyBiotechnology | Polaris Global Equity 2025 Q4 (JAZZ) Ireland-based Jazz Pharmaceuticals announced record quarterly revenues driven by Epidiolex and Xywav. The company also... | BULL | View Pitch → |
| Jan 23, 2026 | Fund Letter | Bernard HornPolaris International Equity | Jazz Pharmaceuticals plc $JAZZ• NASDAQ | BiotechnologyBiotechnology | Polaris International Equity 2025 Q4 (JAZZ) Jazz Pharmaceuticals announced record quarterly revenues driven by Epidiolex and Xywav. The company also... | BULL | View Pitch → |
| Dec 4, 2025 | Fund Letter | Aaron MonroeDiamond Hill Small Cap Fund | Commercial Services & SuppliesCommercial Services & Supplies | Diamond Hill Small Cap Fund 2025 Q2 (AZZ) AZZ is a leading North American metal coating solutions provider that we believe is poised to capitalize on multiple secular drivers — including infrastructure development, manufacturing reshoring and material conversion. We also believe... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.